Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Adenocarcinoma Of Esophagus × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Melanoma 3 Carcinoma, Renal Cell 3 Various Advanced Cancer 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Stomach Neoplasms 1 Neoplasms 1 Microsatellite Unstable Colorectal Cancer 1 Mesothelioma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Advanced Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Ipilimumab 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02872116 2025-08-07

CheckMate649

Bristol-Myers Squibb

Phase 3 Completed

2,031 enrolled 19 charts 1 FDA

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡